Empagliflozin for secondary cardiovascular prevention after myocardial infarction

Activity: Talk or presentation › Poster presentation › science-to-science

Period05 Mar 2020
Event titleRCV Cardio-Metabolic Academy
Event typeConference
LocationAustriaShow on map

Fields of science

  • 305 Other Human Medicine, Health Sciences
  • 304 Medical Biotechnology
  • 303 Health Sciences
  • 302 Clinical Medicine
  • 301 Medical-Theoretical Sciences, Pharmacy